| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DOCK1 ARHGEF19 RAPGEF6 KALRN DOCK8 SH2D3C PSD3 DOCK5 ARHGEF33 SBF2 DNMBP SPATA13 | 9.25e-08 | 231 | 141 | 12 | GO:0005085 |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 1.63e-07 | 8 | 141 | 4 | GO:0032453 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK1 ARHGEF19 RAPGEF6 RASA2 KALRN DOCK8 SH2D3C PSD3 GBP2 DOCK5 ARHGAP5 ARHGEF33 SBF2 DNMBP SPATA13 | 3.11e-06 | 507 | 141 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK1 ARHGEF19 RAPGEF6 RASA2 KALRN DOCK8 SH2D3C PSD3 GBP2 DOCK5 ARHGAP5 ARHGEF33 SBF2 DNMBP SPATA13 | 3.11e-06 | 507 | 141 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 6.79e-06 | 6 | 141 | 3 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 4.28e-05 | 28 | 141 | 4 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 6.46e-05 | 31 | 141 | 4 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 7.35e-05 | 32 | 141 | 4 | GO:0140457 | |
| GeneOntologyMolecularFunction | demethylase activity | 2.60e-04 | 44 | 141 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | STX2 CASP8AP2 KDM5B MYH9 ANK3 MAP1A GAS2L3 SH2D3C RB1CC1 GMNN RCOR1 STX3 KLHL25 ZNF43 CDYL2 MPHOSPH8 MED17 MED13 KDM1A | 5.26e-04 | 1160 | 141 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 6.26e-04 | 24 | 141 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 6.56e-04 | 98 | 141 | 5 | GO:0051213 | |
| GeneOntologyMolecularFunction | WD40-repeat domain binding | 7.29e-04 | 6 | 141 | 2 | GO:0071987 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 1.16e-03 | 65 | 141 | 4 | GO:0016706 | |
| GeneOntologyMolecularFunction | protein kinase binding | MYH9 VRK2 MYO5A PPP1R12B SH2D3C RPS19 RB1CC1 MEF2A RYR2 HNRNPA0 PAM PLCB4 CDC5L UTRN AKAP7 | 1.31e-03 | 873 | 141 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | molecular adaptor activity | STX2 CASP8AP2 KDM5B MYH9 ANK3 MAP1A GAS2L3 SH2D3C RB1CC1 GMNN RCOR1 STX3 KLHL25 ZNF43 CDYL2 MPHOSPH8 MED17 POLK MED13 KDM1A | 1.36e-03 | 1356 | 141 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | kinase binding | MYH9 VRK2 MYO5A PPP1R12B SH2D3C RPS19 RB1CC1 MEF2A RYR2 HNRNPA0 PAM PLCB4 MYOM2 CDC5L UTRN AKAP7 | 1.36e-03 | 969 | 141 | 16 | GO:0019900 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.51e-03 | 118 | 141 | 5 | GO:0003774 | |
| HumanPheno | Dorsocervical fat pad | 1.78e-05 | 17 | 50 | 4 | HP:0025383 | |
| Domain | Lys_sp_deMease-like_dom | 1.64e-06 | 4 | 140 | 3 | IPR013637 | |
| Domain | PLU-1 | 1.64e-06 | 4 | 140 | 3 | PF08429 | |
| Domain | zf-C5HC2 | 4.08e-06 | 5 | 140 | 3 | PF02928 | |
| Domain | Znf_C5HC2 | 4.08e-06 | 5 | 140 | 3 | IPR004198 | |
| Domain | Ank_2 | ANKRD31 ANK3 PPP1R12B TRPC5 ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 3.57e-05 | 215 | 140 | 9 | PF12796 |
| Domain | JmjN | 4.76e-05 | 10 | 140 | 3 | SM00545 | |
| Domain | JmjN | 4.76e-05 | 10 | 140 | 3 | PF02375 | |
| Domain | JMJN | 4.76e-05 | 10 | 140 | 3 | PS51183 | |
| Domain | JmjN | 4.76e-05 | 10 | 140 | 3 | IPR003349 | |
| Domain | Ank | ANKRD31 ANK3 PPP1R12B TRPC5 ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 5.64e-05 | 228 | 140 | 9 | PF00023 |
| Domain | DHR-1_domain | 6.51e-05 | 11 | 140 | 3 | IPR027007 | |
| Domain | DHR_2 | 6.51e-05 | 11 | 140 | 3 | PS51651 | |
| Domain | DHR_1 | 6.51e-05 | 11 | 140 | 3 | PS51650 | |
| Domain | DHR-2 | 6.51e-05 | 11 | 140 | 3 | PF06920 | |
| Domain | DOCK | 6.51e-05 | 11 | 140 | 3 | IPR026791 | |
| Domain | DOCK_C | 6.51e-05 | 11 | 140 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 6.51e-05 | 11 | 140 | 3 | PF14429 | |
| Domain | DHR-2 | 6.51e-05 | 11 | 140 | 3 | IPR027357 | |
| Domain | - | ANKRD31 ANK3 PPP1R12B TRPC5 ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 1.07e-04 | 248 | 140 | 9 | 1.25.40.20 |
| Domain | ANK | ANKRD31 ANK3 PPP1R12B TRPC5 ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 1.18e-04 | 251 | 140 | 9 | SM00248 |
| Domain | ANK_REPEAT | ANKRD31 ANK3 PPP1R12B TRPC5 ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 1.25e-04 | 253 | 140 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD31 ANK3 PPP1R12B TRPC5 ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 1.29e-04 | 254 | 140 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD31 ANK3 PPP1R12B TRPC5 ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 1.29e-04 | 254 | 140 | 9 | PS50297 |
| Domain | RhoGEF | 1.57e-04 | 68 | 140 | 5 | SM00325 | |
| Domain | Ankyrin_rpt | ANKRD31 ANK3 PPP1R12B TRPC5 ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 1.62e-04 | 262 | 140 | 9 | IPR002110 |
| Domain | - | 1.76e-04 | 15 | 140 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 1.76e-04 | 15 | 140 | 3 | SM00501 | |
| Domain | ARID_dom | 1.76e-04 | 15 | 140 | 3 | IPR001606 | |
| Domain | ARID | 1.76e-04 | 15 | 140 | 3 | PS51011 | |
| Domain | ARID | 1.76e-04 | 15 | 140 | 3 | PF01388 | |
| Domain | RhoGEF | 1.80e-04 | 70 | 140 | 5 | PF00621 | |
| Domain | DH_2 | 1.80e-04 | 70 | 140 | 5 | PS50010 | |
| Domain | - | 1.93e-04 | 71 | 140 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.93e-04 | 71 | 140 | 5 | IPR000219 | |
| Domain | DOCK_N | 5.50e-04 | 5 | 140 | 2 | PF16172 | |
| Domain | DOCK_N | 5.50e-04 | 5 | 140 | 2 | IPR032376 | |
| Domain | JmjC | 7.43e-04 | 24 | 140 | 3 | PF02373 | |
| Domain | Znf_FYVE_PHD | 8.48e-04 | 147 | 140 | 6 | IPR011011 | |
| Domain | DH_1 | 1.28e-03 | 63 | 140 | 4 | PS00741 | |
| Domain | RPR | 1.52e-03 | 8 | 140 | 2 | SM00582 | |
| Domain | CID_dom | 1.52e-03 | 8 | 140 | 2 | IPR006569 | |
| Domain | CID | 1.52e-03 | 8 | 140 | 2 | PS51391 | |
| Domain | JMJC | 1.74e-03 | 32 | 140 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.74e-03 | 32 | 140 | 3 | IPR003347 | |
| Domain | JmjC | 1.91e-03 | 33 | 140 | 3 | SM00558 | |
| Domain | SynN | 1.94e-03 | 9 | 140 | 2 | SM00503 | |
| Domain | NHL_repeat_subgr | 1.94e-03 | 9 | 140 | 2 | IPR013017 | |
| Domain | Prefoldin | 2.10e-03 | 72 | 140 | 4 | IPR009053 | |
| Domain | NHL_repeat | 2.41e-03 | 10 | 140 | 2 | IPR001258 | |
| Domain | NHL | 2.41e-03 | 10 | 140 | 2 | PF01436 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 5.15e-05 | 175 | 106 | 8 | MM15599 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 6.21e-05 | 29 | 106 | 4 | MM14934 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 7.34e-05 | 184 | 106 | 8 | M41809 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.92e-04 | 71 | 106 | 5 | MM15604 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 2.33e-04 | 74 | 106 | 5 | M41814 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.38e-04 | 116 | 106 | 6 | MM15715 | |
| Pubmed | MYH9 KRT14 KRT17 ATRX MYO5A KRT19 PPP1R12B PCLO U2SURP ANKRD30B ABCF2 MCM5 RPS19 TUFM RYR2 STX3 SEC62 SYCP1 HNRNPA0 MPHOSPH8 MYOM2 EEA1 DNAH8 MED13 SPATA13 SYNCRIP | 2.07e-10 | 1442 | 143 | 26 | 35575683 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 ANK3 SLC16A9 ATRX RASA2 MYO5A UVSSA TMEM63B FRYL COG3 MEF2A ALX4 DOCK5 STX3 SMPDL3B CLMN SBF2 CDYL2 PDIA5 CAMKMT PLCB4 POLK UTRN GOLGA4 ANKS1A | 2.07e-09 | 1489 | 143 | 25 | 28611215 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT14 KRT17 GAS2L3 MYO5A U2SURP ABCF2 MCM5 DARS1 RPS19 RB1CC1 ADNP TUFM SMPDL3B HNRNPA0 EEA1 CDC5L IK UTRN KDM1A SYNCRIP | 8.52e-09 | 1024 | 143 | 20 | 24711643 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK1 MYH9 ATRX DOCK8 U2SURP MCM5 DOCK5 VPS33B HNRNPA0 CDC5L IK USP48 KDM1A SYNCRIP KIF2C | 2.02e-08 | 582 | 143 | 15 | 20467437 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 ATRX PCLO U2SURP RBM26 ABCF2 MCM5 DARS1 RPS19 ADNP TUFM RPRD1A PPP5C VPS33B HNRNPA0 WDR12 MPHOSPH8 EEA1 CDC5L IK GOLGA4 KDM1A SYNCRIP | 2.06e-08 | 1425 | 143 | 23 | 30948266 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MYH9 KRT17 GBP2 ABCF2 MCM5 DARS1 RPS19 FRYL NHLRC2 COG3 TTC1 TUFM TRMT10A CRYZ RPRD1A PPP5C HNRNPA0 WDR12 DNMBP USP48 USP47 SYNCRIP ANKS1A | 3.01e-08 | 1455 | 143 | 23 | 22863883 |
| Pubmed | VRK2 KRT14 KRT17 ANK3 MYO5A PPP1R12B PSD3 RB1CC1 ARHGAP5 CNNM1 PTPRD PPP5C CLCN7 VPS33B SBF2 CDC5L IK UTRN GOLGA4 | 6.78e-08 | 1049 | 143 | 19 | 27880917 | |
| Pubmed | MYH9 KRT14 DDAH1 ANK3 MAP1A MYO5A KALRN KRT19 DOCK8 PPP1R12B PCLO PSD3 DARS1 RPS19 TUFM ARHGAP5 CLMN SORCS2 HNRNPA0 CDC5L UTRN SYNCRIP | 1.01e-07 | 1431 | 143 | 22 | 37142655 | |
| Pubmed | 1.90e-07 | 13 | 143 | 4 | 24619213 | ||
| Pubmed | MYH9 KRT14 U2SURP CP DARS1 RPS19 TUFM SMPDL3B HNRNPA0 CDC5L USP47 SYNCRIP | 1.93e-07 | 421 | 143 | 12 | 34650049 | |
| Pubmed | 2.66e-07 | 14 | 143 | 4 | 20572855 | ||
| Pubmed | Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. | 2.71e-07 | 4 | 143 | 3 | 16541399 | |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 17320160 | ||
| Pubmed | MYH9 KRT14 KRT17 U2SURP RPS19 TUFM FBP1 HNRNPA0 CDC5L SYNCRIP | 3.30e-07 | 286 | 143 | 10 | 32041737 | |
| Pubmed | MYH9 KRT14 KRT17 PODXL ABCF2 MCM5 RCOR1 VPS33B GOLGA4 SYNCRIP | 4.80e-07 | 298 | 143 | 10 | 30737378 | |
| Pubmed | MYH9 MYO5A U2SURP MCM5 RPS19 FRYL ADNP TUFM WDR12 IK UTRN KDM1A USP47 SYNCRIP | 5.67e-07 | 653 | 143 | 14 | 22586326 | |
| Pubmed | 6.77e-07 | 5 | 143 | 3 | 24365888 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 RASA2 MYO5A U2SURP ABCF2 MCM5 DARS1 RPS19 ADNP TUFM VPS33B SHCBP1 HNRNPA0 CDC5L IK UTRN GOLGA4 KDM1A SYNCRIP KIF2C | 7.54e-07 | 1353 | 143 | 20 | 29467282 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | ATRX KRT19 U2SURP RBM26 HNRNPA0 WDR12 EEA1 CDC5L USP48 UTRN SYNCRIP | 7.80e-07 | 394 | 143 | 11 | 27248496 |
| Pubmed | MYH9 PPP1R12B U2SURP ABCF2 MCM5 DARS1 RPS19 TUFM GSTM3 RCOR1 SMPDL3B PPP5C HNRNPA0 CDC5L IK MED17 MED13 KDM1A SYNCRIP | 9.37e-07 | 1247 | 143 | 19 | 27684187 | |
| Pubmed | CASP8AP2 MYH9 EAPP ATRX KDM5C RBM26 MCM5 ADNP TUFM RCOR1 MPHOSPH8 CDC5L IK MED17 USP48 MED13 KDM1A | 1.02e-06 | 1014 | 143 | 17 | 32416067 | |
| Pubmed | The ZNF217 oncogene is a candidate organizer of repressive histone modifiers. | 1.35e-06 | 6 | 143 | 3 | 19242095 | |
| Pubmed | DOCK1 CASP8AP2 KRT17 ANK3 MAP1A KRT19 PODXL RPS19 TTC1 SMPDL3B DMRT2 RMDN1 SHCBP1 MYOM2 EEA1 TNNI2 USP48 MED13 SPATA13 | 1.60e-06 | 1293 | 143 | 19 | 15342556 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH9 MXRA5 KRT19 PCLO LCA5L HIC2 RPS19 TUFM DOCK5 ARHGAP5 ARHGEF33 ANKRD18A POTEA UTRN | 2.30e-06 | 736 | 143 | 14 | 29676528 |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 2.32e-06 | 92 | 143 | 6 | 15840729 | |
| Pubmed | MYH9 ATRX U2SURP MCM5 HIC2 RPS19 TUFM HNRNPA0 CDC5L IK SYNCRIP | 2.32e-06 | 441 | 143 | 11 | 31239290 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B MYH9 KRT14 MAP1A KALRN U2SURP HIC2 RPS19 ADNP TUFM HNRNPA0 PDIA5 MPHOSPH8 CDC5L IK MED17 SYNCRIP | 2.44e-06 | 1082 | 143 | 17 | 38697112 |
| Pubmed | CASP8AP2 VRK2 EAPP ANK3 ATRX MYO5A PSD3 RB1CC1 TTC1 GSTM3 PPP5C CLCN7 CLMN HNRNPA0 PDIA5 WDR12 CDC5L USP48 GOLGA4 SYNCRIP | 3.18e-06 | 1487 | 143 | 20 | 33957083 | |
| Pubmed | MYH9 U2SURP MCM5 DARS1 FRYL RB1CC1 TUFM ODR4 CDC5L IK SYNCRIP KIF2C | 3.22e-06 | 551 | 143 | 12 | 34728620 | |
| Pubmed | 3.23e-06 | 151 | 143 | 7 | 17043677 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYH9 VRK2 U2SURP RBM26 MCM5 RPS19 ADNP TUFM HNRNPA0 WDR12 MPHOSPH8 CDC5L IK KDM1A SYNCRIP KIF2C | 3.40e-06 | 989 | 143 | 16 | 36424410 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | MYH9 KRT14 KRT17 KRT19 U2SURP MCM5 DARS1 RPS19 TUFM ODR4 CDC5L SYNCRIP | 3.66e-06 | 558 | 143 | 12 | 27591049 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 3.73e-06 | 219 | 143 | 8 | 31353912 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.86e-06 | 220 | 143 | 8 | 35785414 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 RAPGEF6 ATRX KDM5C SEMA5A ZNF224 MYO3A SHCBP1 DNMBP MED13 GOLGA4 CDH17 USP47 ANKS1A | 4.10e-06 | 774 | 143 | 14 | 15302935 |
| Pubmed | The histone demethylase LSD1/KDM1A promotes the DNA damage response. | 5.61e-06 | 9 | 143 | 3 | 24217620 | |
| Pubmed | DOCK1 CASP8AP2 MYH9 VRK2 KRT14 KRT17 ANK3 MAP1A KRT19 NCKAP5 TTC1 | 5.85e-06 | 486 | 143 | 11 | 20936779 | |
| Pubmed | 6.51e-06 | 399 | 143 | 10 | 37536630 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 MYH9 VRK2 ATRX U2SURP ABCF2 RPS19 ADNP DOCK5 RCOR1 HNRNPA0 MPHOSPH8 CDC5L IK MED17 KDM1A SYNCRIP KIF2C | 6.54e-06 | 1294 | 143 | 18 | 30804502 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | MYH9 KRT14 KRT17 KRT19 U2SURP MCM5 RPS19 ADNP HNRNPA0 CDC5L IK SYNCRIP | 8.28e-06 | 605 | 143 | 12 | 28977666 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH9 MYO5A PPP1R12B U2SURP ABCF2 MCM5 DARS1 RPS19 RB1CC1 TUFM HNRNPA0 CDC5L IK SYNCRIP KIF2C | 9.24e-06 | 949 | 143 | 15 | 36574265 |
| Pubmed | CASP8AP2 KDM5B TSHZ3 MYH9 RAPGEF6 RB1CC1 ADNP RCOR1 UTRN KDM1A | 9.76e-06 | 418 | 143 | 10 | 34709266 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 1.02e-05 | 33 | 143 | 4 | 26864203 | |
| Pubmed | RAPGEF6 ANK3 ATRX RASA2 GAS2L3 FRYL ARHGAP5 RCOR1 VPS33B CLMN SBF2 ZMYM1 IK POLK UTRN KIF2C | 1.07e-05 | 1084 | 143 | 16 | 11544199 | |
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 1.15e-05 | 34 | 143 | 4 | 25925205 | |
| Pubmed | 1.21e-05 | 339 | 143 | 9 | 30415952 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | MYH9 KRT14 KRT17 ABCF2 MCM5 RPS19 TUFM HNRNPA0 WDR12 SYNCRIP | 1.25e-05 | 430 | 143 | 10 | 38172120 |
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 1.30e-05 | 342 | 143 | 9 | 23455924 | |
| Pubmed | DOCK8 U2SURP RBM26 MCM5 DARS1 ADNP MEF2A GMNN RCOR1 PPP5C HNRNPA0 IK MED17 KDM1A SYNCRIP KIF2C | 1.33e-05 | 1103 | 143 | 16 | 34189442 | |
| Pubmed | MYH9 KRT14 DDAH1 KRT17 ATRX U2SURP MCM5 DARS1 RPS19 RPRD1A UTRN | 1.51e-05 | 538 | 143 | 11 | 28524877 | |
| Pubmed | 1.62e-05 | 268 | 143 | 8 | 33640491 | ||
| Pubmed | LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition. | 1.68e-05 | 2 | 143 | 2 | 22802671 | |
| Pubmed | Crystal Structure of the LSD1/CoREST Histone Demethylase Bound to Its Nucleosome Substrate. | 1.68e-05 | 2 | 143 | 2 | 32396821 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 24168496 | ||
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 1.68e-05 | 2 | 143 | 2 | 10441747 | |
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 1.68e-05 | 2 | 143 | 2 | 16416087 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 26226427 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 32081420 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 21142040 | ||
| Pubmed | LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. | 1.68e-05 | 2 | 143 | 2 | 21602794 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 17431507 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 29161028 | ||
| Pubmed | Extranucleosomal DNA enhances the activity of the LSD1/CoREST histone demethylase complex. | 1.68e-05 | 2 | 143 | 2 | 25916846 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 16885027 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 2433272 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 30488434 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 7524912 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 35468265 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 28832116 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 20871598 | ||
| Pubmed | Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach. | 1.68e-05 | 2 | 143 | 2 | 30066921 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 25730864 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 9529381 | ||
| Pubmed | Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. | 1.68e-05 | 2 | 143 | 2 | 9060413 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 30336116 | ||
| Pubmed | MYH9 U2SURP RBM26 ABCF2 MCM5 HIC2 TUFM SEC62 PDIA5 EEA1 CDC5L IK | 1.76e-05 | 653 | 143 | 12 | 33742100 | |
| Pubmed | MYH9 KRT19 U2SURP ABCF2 DARS1 RPS19 TUFM RCOR1 WDR12 CDC5L KDM1A SYNCRIP | 1.82e-05 | 655 | 143 | 12 | 35819319 | |
| Pubmed | MYH9 DDAH1 MYO5A DARS1 TUFM GSTM3 STX3 VPS33B HNRNPA0 USP48 SYNCRIP | 1.91e-05 | 552 | 143 | 11 | 36293380 | |
| Pubmed | 1.95e-05 | 360 | 143 | 9 | 33111431 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYH9 MXRA5 DDAH1 KALRN PODXL CP TRMT10A CRYZ STX3 FBP1 SMPDL3B GSTCD EEA1 UTRN ZNF114 | 2.05e-05 | 1016 | 143 | 15 | 19056867 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.16e-05 | 202 | 143 | 7 | 33005030 | |
| Pubmed | KDM5B ANK3 ATRX MYO5A KALRN NAP1L3 DARS1 NCKAP5 ZNF224 ARHGAP5 PTPRD RPRD1A PPP5C ST18 UTRN MED13 USP47 | 2.28e-05 | 1285 | 143 | 17 | 35914814 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | MYH9 KRT14 DDAH1 KRT17 MAP1A MYO5A RPS19 TUFM EEA1 GOLGA4 KIF2C | 2.33e-05 | 564 | 143 | 11 | 21565611 |
| Pubmed | 2.40e-05 | 14 | 143 | 3 | 12432077 | ||
| Pubmed | DOCK1 ARHGEF19 MYO5A DOCK8 MCM5 DOCK5 ARHGAP5 RPRD1A SHCBP1 DNMBP UTRN GOLGA4 KDM1A SPATA13 | 2.69e-05 | 916 | 143 | 14 | 32203420 | |
| Pubmed | KDM5B VRK2 ZNF224 CRYZ STX3 VPS33B SYCP1 PAM PLCB4 CEP126 GOLGA4 AKAP7 | 2.85e-05 | 686 | 143 | 12 | 29987050 | |
| Pubmed | 2.99e-05 | 15 | 143 | 3 | 10087197 | ||
| Pubmed | 3.09e-05 | 87 | 143 | 5 | 12465718 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH9 ANK3 PCLO CP DARS1 NHLRC2 COG3 TUFM GSTM3 FBP1 EEA1 UTRN SYNCRIP | 3.09e-05 | 807 | 143 | 13 | 30575818 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | U2SURP HIC2 RPS19 RB1CC1 ADNP TUFM RCOR1 CDC5L IK KDM1A SYNCRIP | 3.15e-05 | 583 | 143 | 11 | 29844126 |
| Pubmed | 3.16e-05 | 383 | 143 | 9 | 29331416 | ||
| Pubmed | MYH9 U2SURP MCM5 DARS1 RPS19 TUFM GSTM3 HNRNPA0 EEA1 CDC5L KDM1A SYNCRIP KIF2C | 3.17e-05 | 809 | 143 | 13 | 32129710 | |
| Pubmed | 3.22e-05 | 295 | 143 | 8 | 26209609 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYH9 RAPGEF6 ATRX MAP1A U2SURP RBM26 DARS1 RPS19 TTC1 ADNP CLMN CDC5L UTRN ANKS1A | 3.33e-05 | 934 | 143 | 14 | 33916271 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CASP8AP2 KRT14 ATRX MAP1A KRT19 KDM5C RPS19 POLK DNMBP KDM1A KIF2C | 3.40e-05 | 588 | 143 | 11 | 38580884 |
| Pubmed | TSHZ3 MAP1A ANKRD30B MCM5 DARS1 RPS19 ADNP TUFM RCOR1 RPRD1A PPP5C SHCBP1 HNRNPA0 CDC5L MED17 KDM1A SYNCRIP | 3.68e-05 | 1335 | 143 | 17 | 29229926 | |
| Pubmed | DOCK1 MYH9 ANK3 PSD3 ABCF2 DARS1 RPS19 MED17 GOLGA4 SYNCRIP KIF2C ANKS1A | 3.87e-05 | 708 | 143 | 12 | 39231216 | |
| Pubmed | 4.07e-05 | 305 | 143 | 8 | 33194618 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.26e-05 | 497 | 143 | 10 | 36774506 | |
| Pubmed | VRK2 ATRX MYO5A PPP1R12B RBM26 ABCF2 MCM5 TUFM GSTM3 CDYL2 WDR12 MPHOSPH8 IK DNMBP UTRN MED13 KDM1A KIF2C | 4.52e-05 | 1497 | 143 | 18 | 31527615 | |
| Interaction | UFL1 interactions | KDM5B MYH9 KRT14 PCLO U2SURP CASP4 ABCF2 MCM5 DARS1 HIC2 RPS19 FRYL RB1CC1 TUFM GSTM3 ODR4 SEC62 HNRNPA0 CDC5L IK SYNCRIP | 8.97e-06 | 1031 | 140 | 21 | int:UFL1 |
| Interaction | ATG16L1 interactions | STX2 ANK3 MAP1A RASA2 MYO5A RBM26 ABCF2 MCM5 DARS1 CCDC168 RB1CC1 TUFM RYR2 VPS33B SHCBP1 HNRNPA0 PDIA5 MPHOSPH8 IK MED17 DNMBP KDM1A | 1.66e-05 | 1161 | 140 | 22 | int:ATG16L1 |
| Interaction | KRT7 interactions | 1.99e-05 | 80 | 140 | 6 | int:KRT7 | |
| Interaction | GAPDH interactions | TSHZ3 MYH9 KRT17 MCM5 TUFM GSTM3 CRYZ STX3 PPP5C SEC62 HNRNPA0 CDC5L USP48 GOLGA4 AKAP7 SYNCRIP | 2.31e-05 | 686 | 140 | 16 | int:GAPDH |
| Interaction | MRTFB interactions | 4.72e-05 | 57 | 140 | 5 | int:MRTFB | |
| Interaction | PCNT interactions | 4.85e-05 | 241 | 140 | 9 | int:PCNT | |
| Interaction | CCDC8 interactions | KRT14 GAS2L3 MYO5A ABCF2 MCM5 DARS1 RPS19 RB1CC1 ADNP TUFM SMPDL3B HNRNPA0 EEA1 UTRN SYNCRIP | 5.29e-05 | 656 | 140 | 15 | int:CCDC8 |
| Interaction | NEFM interactions | 5.57e-05 | 190 | 140 | 8 | int:NEFM | |
| Interaction | USP47 interactions | 5.57e-05 | 190 | 140 | 8 | int:USP47 | |
| Interaction | KRT79 interactions | 5.58e-05 | 59 | 140 | 5 | int:KRT79 | |
| Interaction | PFN1 interactions | DOCK1 MYH9 RAPGEF6 KRT17 MAP1A MYO5A DOCK8 PCLO NHLRC2 ARHGAP5 DNMBP USP48 GOLGA4 | 5.66e-05 | 509 | 140 | 13 | int:PFN1 |
| Interaction | MYH9 interactions | MYH9 GAS2L3 MYO5A PPP1R12B CASP4 MCM5 TUFM RCOR1 FBP1 PPP5C MYOM2 CDC5L USP48 GOLGA4 KDM1A USP47 | 7.14e-05 | 754 | 140 | 16 | int:MYH9 |
| Interaction | WDR76 interactions | MYH9 KRT19 U2SURP MCM5 TUFM HNRNPA0 EEA1 USP48 UTRN KDM1A SYNCRIP | 7.69e-05 | 383 | 140 | 11 | int:WDR76 |
| Interaction | TRIM31 interactions | MYH9 KRT14 U2SURP CP DARS1 RPS19 TUFM SMPDL3B HNRNPA0 CDC5L USP47 SYNCRIP | 7.98e-05 | 454 | 140 | 12 | int:TRIM31 |
| Interaction | RNF2 interactions | ANK3 KDM5C PCLO MCM5 RPS19 ADNP GMNN TUFM SHCBP1 HNRNPA0 WDR12 EEA1 CDC5L IK MED17 KDM1A SYNCRIP | 1.09e-04 | 866 | 140 | 17 | int:RNF2 |
| Interaction | ENO1 interactions | STX2 FILIP1 MYH9 RAPGEF6 KRT17 ANK3 MCM5 GSTM3 FBP1 PPP5C SYCP1 MPHOSPH8 USP48 DNAH8 MED13 | 1.11e-04 | 701 | 140 | 15 | int:ENO1 |
| Interaction | YWHAZ interactions | KDM5B MYH9 RAPGEF6 KRT17 MYO5A SH2D3C RBM26 PSD3 FRYL RB1CC1 TUFM FSIP2 MYO3A RPRD1A SHCBP1 CEP126 CDC5L DNMBP USP48 USP47 SPATA13 ANKS1A | 1.12e-04 | 1319 | 140 | 22 | int:YWHAZ |
| Interaction | CALM1 interactions | CASP8AP2 MYH9 DDAH1 ATRX MYO5A SPP1 KDM5C RYR2 MYO3A PAM CAMKMT CDC5L TNNI2 UTRN | 1.20e-04 | 626 | 140 | 14 | int:CALM1 |
| GeneFamily | PHD finger proteins|Lysine demethylases | 5.91e-06 | 24 | 91 | 4 | 485 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.03e-05 | 66 | 91 | 5 | 722 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD31 ANK3 PPP1R12B ANKRD30B ANKRD18A MPHOSPH8 POTEA ANKS1A | 3.00e-05 | 242 | 91 | 8 | 403 |
| GeneFamily | AT-rich interaction domain containing | 5.37e-05 | 15 | 91 | 3 | 418 | |
| GeneFamily | Keratins, type I | 3.69e-04 | 28 | 91 | 3 | 608 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.21e-03 | 181 | 91 | 5 | 694 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.52e-03 | 15 | 91 | 2 | 529 | |
| GeneFamily | Syntaxins | 2.87e-03 | 16 | 91 | 2 | 818 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 RAPGEF6 MYO5A SPP1 PODXL RBM26 NAP1L3 RB1CC1 TTC1 ARHGAP5 ZNF43 SEC62 MPHOSPH8 ZMYM1 EEA1 CDC5L POLK USP48 GOLGA4 USP47 | 5.15e-10 | 656 | 143 | 20 | M18979 |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP | DOCK1 CASP8AP2 KDM5B UVSSA GSTM3 PAM PDIA5 PLCB4 GALNT6 DNMBP GOLGA4 | 1.39e-08 | 200 | 143 | 11 | M318 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TSHZ3 SLC16A9 ATRX MAP1A MYO5A PCLO U2SURP PSD3 SEMA5A DARS1 ARHGAP5 MYO3A STX3 MPHOSPH8 PLCB4 CDC5L USP48 ST18 UTRN GOLGA4 | 2.27e-07 | 946 | 143 | 20 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.72e-07 | 212 | 143 | 10 | M39221 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | CASP8AP2 ANK3 ATRX MAP1A KALRN PCLO PSD3 DARS1 RB1CC1 TTC1 MEF2A TUFM AZIN1 GSTM3 CNNM1 RCOR1 CRYZ VPS33B PAM WDR12 CDC5L MED17 SYNCRIP | 2.95e-07 | 1248 | 143 | 23 | M17728 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 KDM5B ATRX PODXL U2SURP PSD3 SEMA5A FRYL RB1CC1 ADNP MEF2A AZIN1 RCOR1 PLCB4 DNMBP MED13 GOLGA4 ANKS1A | 1.04e-06 | 856 | 143 | 18 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 1.96e-06 | 38 | 143 | 5 | M39244 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 5.79e-06 | 176 | 143 | 8 | M39223 | |
| Coexpression | GSE2826_WT_VS_XID_BCELL_DN | 1.47e-05 | 200 | 143 | 8 | M4897 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KRT14 RAPGEF6 ANK3 SLC16A9 ATRX MYO5A PCLO RBM26 NAP1L3 RB1CC1 RYR2 FSIP2 SBF2 ANKRD18A PLCB4 CEP126 EEA1 SPATA13 | 3.44e-05 | 1106 | 143 | 18 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 5.49e-05 | 177 | 143 | 7 | M39245 | |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN | 6.11e-05 | 180 | 143 | 7 | M6317 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYH9 RAPGEF6 ATRX RASA2 MYO5A DOCK8 U2SURP SH2D3C RBM26 GBP2 DARS1 RPS19 FRYL RB1CC1 AZIN1 MPHOSPH8 IK UTRN MED13 USP47 SPATA13 | 6.11e-05 | 1492 | 143 | 21 | M40023 |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | KRT14 KRT17 RASA2 SPP1 CP MCM5 OCA2 SMPDL3B SHCBP1 PLCB4 CDC5L TNNI2 SYNCRIP | 7.19e-05 | 662 | 143 | 13 | M8124 |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 8.89e-05 | 43 | 143 | 4 | M1551 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 8.89e-05 | 43 | 143 | 4 | MM666 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 1.01e-04 | 195 | 143 | 7 | M1110 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.08e-04 | 265 | 143 | 8 | M1684 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN | 1.18e-04 | 200 | 143 | 7 | M8647 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP | 1.18e-04 | 200 | 143 | 7 | M7195 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP | 1.18e-04 | 200 | 143 | 7 | M9860 | |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP | 1.18e-04 | 200 | 143 | 7 | M7489 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 1.18e-04 | 200 | 143 | 7 | M6611 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP | 1.18e-04 | 200 | 143 | 7 | M5700 | |
| Coexpression | GSE7764_NKCELL_VS_SPLENOCYTE_DN | 1.18e-04 | 200 | 143 | 7 | M5722 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.18e-04 | 200 | 143 | 7 | M6993 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.29e-04 | 272 | 143 | 8 | MM1027 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 SEMA5A GMNN AZIN1 CRYZ SHCBP1 MPHOSPH8 IK SYNCRIP KIF2C | 1.41e-04 | 434 | 143 | 10 | M15150 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 1.46e-04 | 207 | 143 | 7 | MM475 | |
| Coexpression | WANG_LMO4_TARGETS_DN | 1.70e-04 | 361 | 143 | 9 | M12674 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 SEMA5A GMNN AZIN1 CRYZ SHCBP1 MPHOSPH8 IK SYNCRIP KIF2C | 1.82e-04 | 448 | 143 | 10 | MM1044 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | DOCK1 KDM5B MYH9 DDAH1 KRT17 ANK3 KRT19 SPP1 CASP4 GBP2 RB1CC1 GMNN CRYZ CLMN PDIA5 UTRN AKAP7 SYNCRIP | 2.09e-04 | 1276 | 143 | 18 | M39173 |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_PODOCYTE_AGEING | 2.24e-04 | 222 | 143 | 7 | MM3733 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.08e-06 | 191 | 140 | 9 | gudmap_kidney_adult_Podocyte_MafB_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | CASP8AP2 DDAH1 KRT17 ATRX MAP1A PCLO U2SURP TMEM63B PSD3 ABCC9 NCKAP5 FRYL STX3 PTPRD SMPDL3B GSTCD MPHOSPH8 CEP126 ST18 SPATA13 | 7.49e-06 | 986 | 140 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | DOCK1 MYH9 RAPGEF6 DDAH1 ANK3 ATRX DOCK8 SEMA5A MCM5 CCDC160 STX3 PAM DNMBP UTRN MED13 SPATA13 SYNCRIP | 1.97e-05 | 795 | 140 | 17 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.02e-05 | 261 | 140 | 9 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | DOCK1 FILIP1 TSHZ3 MYH9 RAPGEF6 GAS2L3 PPP1R12B SEMA5A ADAMDEC1 PLCB4 SYNCRIP | 6.10e-05 | 393 | 140 | 11 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 6.97e-05 | 266 | 140 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | KRT14 KRT17 KRT19 SPP1 CASP4 GSTM3 DMRT2 PAM PLCB4 ALOX15 CDH17 | 9.08e-05 | 411 | 140 | 11 | GSM854302_500 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | FILIP1 MYH9 RASA2 PODXL PSD3 SEMA5A FRYL RB1CC1 DOCK5 ARHGAP5 PTPRD ODR4 SBF2 SEC62 PAM MYOM2 | 1.33e-04 | 838 | 140 | 16 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | FILIP1 CASP8AP2 DDAH1 ATRX MAP1A MYO5A PODXL CP NCKAP5 GSTM3 ARHGAP5 FBP1 ADAMDEC1 VPS33B MPHOSPH8 PLCB4 ZMYM1 GALNT6 CEP126 ALOX15 SPATA13 KIF2C | 1.44e-04 | 1414 | 140 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.88e-04 | 179 | 140 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | DOCK1 MYH9 ANK3 KRT19 DOCK8 MCM5 NCKAP5 STX3 PTPRD PLCB4 USP48 UTRN MED13 CDH17 SYNCRIP | 2.13e-04 | 784 | 140 | 15 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.14e-04 | 379 | 140 | 10 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | 2.38e-04 | 384 | 140 | 10 | GSM777041_500 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | ATRX PPP1R12B PCLO U2SURP ABCC9 RB1CC1 TTC1 EEA1 UTRN GOLGA4 | 9.79e-10 | 199 | 143 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.17e-09 | 185 | 143 | 9 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.06e-08 | 188 | 143 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-08 | 188 | 143 | 9 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-08 | 190 | 143 | 9 | 6b101359f397020a21e2bfd15851cb48e71f4502 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-08 | 190 | 143 | 9 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.39e-08 | 194 | 143 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-07 | 177 | 143 | 8 | 0721199be6d29777dc0f47845aafd027fd376a32 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 178 | 143 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-07 | 183 | 143 | 8 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-07 | 183 | 143 | 8 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-07 | 184 | 143 | 8 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-07 | 184 | 143 | 8 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-07 | 185 | 143 | 8 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-07 | 186 | 143 | 8 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-07 | 186 | 143 | 8 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-07 | 187 | 143 | 8 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-07 | 187 | 143 | 8 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-07 | 188 | 143 | 8 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-07 | 188 | 143 | 8 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-07 | 189 | 143 | 8 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.83e-07 | 189 | 143 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.91e-07 | 190 | 143 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.91e-07 | 190 | 143 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.98e-07 | 191 | 143 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-07 | 191 | 143 | 8 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-07 | 192 | 143 | 8 | f3133bbbf938a39062a9b1d1181003bb48174695 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-07 | 193 | 143 | 8 | c13e2612330ca8b9a8c206e588b26025c4f5898c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-07 | 194 | 143 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.24e-07 | 194 | 143 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.51e-07 | 197 | 143 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.71e-07 | 199 | 143 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.71e-07 | 199 | 143 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-06 | 165 | 143 | 7 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 172 | 143 | 7 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-06 | 174 | 143 | 7 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-06 | 174 | 143 | 7 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-06 | 179 | 143 | 7 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-06 | 180 | 143 | 7 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-06 | 181 | 143 | 7 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 181 | 143 | 7 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.08e-06 | 182 | 143 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | facs-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 182 | 143 | 7 | 45faefd7cbeac84d2c58650530b902af6ce921f8 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 182 | 143 | 7 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-06 | 183 | 143 | 7 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.23e-06 | 184 | 143 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-06 | 186 | 143 | 7 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-06 | 187 | 143 | 7 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 187 | 143 | 7 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 187 | 143 | 7 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 2.49e-06 | 187 | 143 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-06 | 188 | 143 | 7 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-06 | 189 | 143 | 7 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-06 | 189 | 143 | 7 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-06 | 189 | 143 | 7 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-06 | 189 | 143 | 7 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-06 | 190 | 143 | 7 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.76e-06 | 190 | 143 | 7 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-06 | 190 | 143 | 7 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.86e-06 | 191 | 143 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.86e-06 | 191 | 143 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.86e-06 | 191 | 143 | 7 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.17e-06 | 194 | 143 | 7 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.28e-06 | 195 | 143 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 195 | 143 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 195 | 143 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-06 | 196 | 143 | 7 | 37a5f9f3988778655580bd0383811bb4930c1551 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.51e-06 | 197 | 143 | 7 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.51e-06 | 197 | 143 | 7 | f870a26f322668781e3d2832c5d9ef2c7c91011f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.63e-06 | 198 | 143 | 7 | 50852713c017217c79777c95857097103bcf2fbe | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 3.63e-06 | 198 | 143 | 7 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 3.63e-06 | 198 | 143 | 7 | cd8a26de6c1cb9c42635146bb7220dd1b41ee97d | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.63e-06 | 198 | 143 | 7 | 82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-06 | 199 | 143 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.75e-06 | 199 | 143 | 7 | 180b3997174fd63bdf3b828063a13483eb4cab29 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.75e-06 | 199 | 143 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.75e-06 | 199 | 143 | 7 | ca78fd6e310232b25b864ed02ff9242fe1aa8206 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.75e-06 | 199 | 143 | 7 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.75e-06 | 199 | 143 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-06 | 199 | 143 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.75e-06 | 199 | 143 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.75e-06 | 199 | 143 | 7 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.75e-06 | 199 | 143 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.87e-06 | 200 | 143 | 7 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-06 | 200 | 143 | 7 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 3.87e-06 | 200 | 143 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 3.87e-06 | 200 | 143 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-06 | 200 | 143 | 7 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 8.12e-06 | 147 | 143 | 6 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 1.36e-05 | 161 | 143 | 6 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 168 | 143 | 6 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 169 | 143 | 6 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 170 | 143 | 6 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 170 | 143 | 6 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| Drug | Succimer | CASP8AP2 TSHZ3 ANK3 ATRX RASA2 SPP1 TRPC5 RBM26 CASP4 CP SEMA5A MEF2A GMNN FBP1 CLMN WDR12 PLCB4 ST18 UTRN MED13 GOLGA4 USP47 SPATA13 SYNCRIP | 9.97e-07 | 1264 | 142 | 24 | ctd:D004113 |
| Drug | Magnetite Nanoparticles | CASP8AP2 TSHZ3 ANK3 ATRX RASA2 SPP1 RBM26 CASP4 CP SEMA5A MEF2A GMNN GSTM3 FBP1 CLMN WDR12 PLCB4 ST18 UTRN MED13 GOLGA4 USP47 SPATA13 SYNCRIP | 1.87e-06 | 1310 | 142 | 24 | ctd:D058185 |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 3.12e-06 | 190 | 142 | 9 | 4507_DN | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 4.26e-07 | 4 | 141 | 3 | DOID:0060809 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | FILIP1 VRK2 DDAH1 KRT17 ANK3 PODXL PPP1R12B SEMA5A NCKAP5 FRYL ALX4 TUFM FBP1 DMRT2 RMDN1 PAM CDC5L KDM1A ANKS1A | 2.31e-05 | 1345 | 141 | 19 | EFO_0010736 |
| Disease | intellectual disability (implicated_via_orthology) | 3.06e-05 | 75 | 141 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 5.71e-05 | 16 | 141 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.36e-05 | 152 | 141 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 1.35e-04 | 4 | 141 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | heel bone mineral density, urate measurement | 2.50e-04 | 182 | 141 | 6 | EFO_0004531, EFO_0009270 | |
| Disease | chronotype measurement | DOCK1 TSHZ3 VRK2 KRT17 ANK3 PODXL UVSSA MCM5 PTPRD CAMKMT PLCB4 USP48 ST18 | 3.27e-04 | 882 | 141 | 13 | EFO_0008328 |
| Disease | Carcinoma, Lobular | 3.36e-04 | 6 | 141 | 2 | C0206692 | |
| Disease | susceptibility to mononucleosis measurement | 3.39e-04 | 69 | 141 | 4 | EFO_0008403 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.61e-04 | 195 | 141 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | gout | 3.71e-04 | 196 | 141 | 6 | EFO_0004274 | |
| Disease | interleukin 10 measurement | 5.42e-04 | 78 | 141 | 4 | EFO_0004750 | |
| Disease | Colonic Neoplasms | 8.37e-04 | 152 | 141 | 5 | C0009375 | |
| Disease | Moyamoya disease | 9.27e-04 | 40 | 141 | 3 | MONDO_0016820 | |
| Disease | coffee consumption measurement, insomnia | 9.95e-04 | 10 | 141 | 2 | EFO_0004698, EFO_0006781 | |
| Disease | creativity measurement | 9.95e-04 | 10 | 141 | 2 | EFO_0010650 | |
| Disease | Malignant tumor of colon | 1.02e-03 | 159 | 141 | 5 | C0007102 | |
| Disease | high grade glioma (is_implicated_in) | 1.07e-03 | 42 | 141 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | age at assessment, pelvic organ prolapse | 1.15e-03 | 43 | 141 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | Tachycardia, Ventricular | 1.21e-03 | 11 | 141 | 2 | C0042514 | |
| Disease | Diabetic Cardiomyopathies | 1.21e-03 | 11 | 141 | 2 | C0853897 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.43e-03 | 447 | 141 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.45e-03 | 12 | 141 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | forced expiratory volume | FILIP1 TSHZ3 KRT17 PODXL PSD3 MEF2A RYR2 DMRT2 GSTCD CDC5L ANKS1A | 1.48e-03 | 789 | 141 | 11 | EFO_0004314 |
| Disease | serum gamma-glutamyl transferase measurement | ARHGEF19 ATRX MAP1A KALRN PSD3 RYR2 RCOR1 DNMBP MED13 GOLGA4 KDM1A SPATA13 | 1.50e-03 | 914 | 141 | 12 | EFO_0004532 |
| Disease | immature platelet fraction | 2.22e-03 | 114 | 141 | 4 | EFO_0009187 | |
| Disease | Opioid use measurement | 2.29e-03 | 15 | 141 | 2 | EFO_0009937 | |
| Disease | schizophrenia (biomarker_via_orthology) | 2.29e-03 | 15 | 141 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | third ventricle volume measurement | 2.29e-03 | 15 | 141 | 2 | EFO_0010335 | |
| Disease | vital capacity | FILIP1 VRK2 KRT17 PODXL PCLO RYR2 PTPRD DMRT2 GSTCD SYCP1 CDC5L UTRN AKAP7 ANKS1A | 2.45e-03 | 1236 | 141 | 14 | EFO_0004312 |
| Disease | osteosarcoma (is_implicated_in) | 2.60e-03 | 16 | 141 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | peak expiratory flow | 2.79e-03 | 498 | 141 | 8 | EFO_0009718 | |
| Disease | Fetal Alcohol Syndrome | 2.94e-03 | 17 | 141 | 2 | C0015923 | |
| Disease | urate measurement, bone density | 3.00e-03 | 619 | 141 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | mean platelet volume | MYH9 MYO5A KALRN DOCK8 U2SURP PSD3 FRYL AZIN1 DOCK5 RCOR1 PDIA5 ANKS1A | 3.68e-03 | 1020 | 141 | 12 | EFO_0004584 |
| Disease | exercise test | 4.07e-03 | 20 | 141 | 2 | EFO_0004328 | |
| Disease | synophrys measurement | 4.27e-03 | 68 | 141 | 3 | EFO_0007906 | |
| Disease | Nonorganic psychosis | 4.45e-03 | 69 | 141 | 3 | C0349204 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.49e-03 | 21 | 141 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | Arthrogryposis | 4.49e-03 | 21 | 141 | 2 | C0003886 | |
| Disease | Malignant Glioma | 4.63e-03 | 70 | 141 | 3 | C0555198 | |
| Disease | mixed gliomas | 4.63e-03 | 70 | 141 | 3 | C0259783 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEELEKVFQKTHYPD | 226 | Q9H161 | |
| EKEHKAEKVPAVANY | 466 | Q9H2P0 | |
| KLDQKEDGSKYETIH | 926 | Q9H2P0 | |
| YKEHLKSKLVDEEPQ | 601 | Q9UG63 | |
| LEHNPYEKFSKEELK | 616 | Q99459 | |
| KLEEIHLQKQAEYEK | 836 | Q8IVF6 | |
| NHLKERIDQYEKEKA | 1356 | Q9BXX2 | |
| DLNTIPEVHKKYKED | 331 | O14977 | |
| VKKIDPDLYEKFISH | 236 | Q9P0M2 | |
| HDEKKPDVLLYDTIF | 221 | P49662 | |
| EEYVTKDHPDKLKEA | 231 | A8MVX0 | |
| KKQHKIPTNDELLYD | 126 | Q56P03 | |
| HHKETEYKDKIPLLQ | 361 | P19021 | |
| EIYEKDEKIQKHLQD | 881 | Q6XZF7 | |
| DAYEEQKKKVADHPN | 266 | O60706 | |
| DEHPYELLLTAETKK | 451 | Q92625 | |
| LLKEKLSKSEDPVHY | 1191 | Q9UKL3 | |
| HFQYLVEKPKIKEND | 26 | Q8N0U7 | |
| EAKLDEYIAIAKEKH | 146 | Q9UKL0 | |
| EFFPHQEKDIKKEEI | 96 | Q5T8P6 | |
| LYNKEPSEIVELKHE | 536 | Q04671 | |
| VVDPKSKEEDKHLKF | 286 | P10451 | |
| DDSEHEKIILYKKNL | 121 | Q9H8K7 | |
| SIIEKLDEPHEKYRK | 816 | Q15283 | |
| DHTVYKLPEKLDFKQ | 111 | Q08257 | |
| KKLDEIEAIYHIEVK | 356 | Q6ZRR7 | |
| YKALHPDELTLEKTD | 726 | Q8IW93 | |
| LDDNIKTYSDHPEKV | 931 | P00450 | |
| LDIEDVYQHKKPKFS | 626 | Q8N7Z5 | |
| EKHQKELLSLKNEYE | 861 | Q8TDY2 | |
| HTKEPETYKKKVAEQ | 261 | Q7RTY1 | |
| HTKLPAKDVYERLKD | 416 | O00592 | |
| GLKEELAYLKKNHEE | 206 | P08727 | |
| HKEVVEPKDTAIYQK | 1376 | P78559 | |
| EPKDTAIYQKDEALH | 1381 | P78559 | |
| EHSIIKDFTKQKYPE | 691 | P33992 | |
| HLKQKDKLPDDHYQE | 696 | Q86WG5 | |
| HLQEELEEKNKKYSL | 1796 | Q13439 | |
| SLKEELAYLKKNHEE | 241 | P02533 | |
| IADLHLDPDYKVSKD | 26 | Q92485 | |
| FDNEVKDKEYKPHSI | 181 | Q9BY66 | |
| DIEKHPELKKLQIYG | 226 | Q9BY66 | |
| IPTDKKGKDDEIYTH | 5571 | Q5CZC0 | |
| SEQPKKIKEDYFEKH | 276 | Q9H3M9 | |
| KEIPHNEKLLSLKYE | 81 | P51798 | |
| TDVILYHQPDDKKKN | 271 | O60506 | |
| DNIHLEKPQYKEDGK | 2706 | Q9Y6V0 | |
| EDPYELKLLKHQIKQ | 4116 | Q9Y6V0 | |
| LNEIPEKKDSEKEFH | 326 | Q5SWX8 | |
| EKKDSEKEFHVLPYR | 331 | Q5SWX8 | |
| LDATKKLYHSQKDDP | 491 | Q96JB1 | |
| DNKPIKENIEESYVH | 1496 | O94915 | |
| KELEKYEQLPEDVGH | 1346 | O60229 | |
| LHYKTDVAVKDDPEL | 481 | P16050 | |
| ILKNLHDTEDYPKVS | 341 | O95447 | |
| PKKYLAHLEQLKEEE | 241 | P32456 | |
| SSDHEKLKPQYLEEL | 121 | P21266 | |
| TDTKDKEYKPHDIPQ | 201 | Q9UGL1 | |
| HEEKVAAYDKLEKTK | 1401 | P35579 | |
| KNTDLDLDKKIPEDY | 226 | Q9NVC6 | |
| EAKKTYVRDKPHVNV | 46 | P49411 | |
| VLTPHTEEKYKKINE | 106 | Q02078 | |
| VADSYNHKIKVVDPK | 491 | Q8NBF2 | |
| SPDDVLEFLKVYEKH | 321 | P09467 | |
| KLKEELSEVETKYQH | 376 | Q15075 | |
| GEHKKSDRKEEPQYE | 491 | P46100 | |
| KELHQQYKEASEVKP | 456 | O60341 | |
| YQVDHKAKEIIPKAD | 311 | Q9H0H3 | |
| LKEELAYLKKNHEEE | 211 | Q04695 | |
| IPDKDHLSEEKNFKE | 131 | A0A1B0GVN3 | |
| DGEHDLIVYKAEAKK | 546 | Q14185 | |
| FTEKYLQEHPEDQEK | 1571 | Q9H7D0 | |
| HNKSPDFYEEVKIKL | 621 | Q8NF50 | |
| FVKEAFEETPKKHRE | 491 | Q9Y5R5 | |
| YIPHNPDSKDEKQKL | 526 | Q9P2H0 | |
| PEIREHYLDSKKDVD | 676 | Q96JB2 | |
| KPTAKKKEDDDHYFV | 671 | Q86XJ1 | |
| TPLETQEKEEGYKKH | 126 | Q8NCL4 | |
| AESEKIKKHFEEAYP | 251 | Q5T3F8 | |
| EEFENAEKELLHYKK | 166 | A6NGH7 | |
| ESDKKHHYLPEKEVD | 3266 | Q12955 | |
| DKLDNIQAYKPDDLK | 6366 | Q8NDH2 | |
| SYPLEIHVKVKDIND | 321 | Q12864 | |
| VLPKEKLKVEHSREY | 826 | Q92736 | |
| HIIQKSYEADPLKKE | 111 | Q8NEC7 | |
| VHEPKLKVDLTKYLE | 291 | Q99661 | |
| EYPESAKVYEKLKDH | 241 | O94760 | |
| IPLDFKTIDDHKTKE | 471 | Q99549 | |
| LSPKDKKVELFHYQD | 101 | Q14554 | |
| IQHKPKNSEELYKEI | 356 | P23468 | |
| IEEYHRPEKKSNEKN | 391 | Q6S8J7 | |
| YEALKENEKLHKEIE | 111 | O75496 | |
| EKTYKDPATLRQHEK | 511 | Q96JB3 | |
| KNVHPDVEKLYKQEF | 976 | P46939 | |
| EEKQKHLDKIYQERA | 161 | Q2YD98 | |
| KLPSKYEKHLQDLQD | 971 | Q8TEU7 | |
| TVKLAKHKELAPYDE | 36 | P39019 | |
| AQYDKEKSTHEKILE | 966 | Q15147 | |
| LKTEKTKPEVLEAHY | 101 | Q7Z7B0 | |
| VYQEKLSEEERKHKE | 141 | O14513 | |
| LRDYETVVKVKPHDK | 116 | P53041 | |
| HPKEEDKVLAYTKES | 256 | Q96PQ0 | |
| EVLVKTYIIKAKPDH | 371 | Q99457 | |
| PNEKLLGHLVKEKYD | 371 | P14868 | |
| KTVSNKLKNHPDYEE | 291 | Q13017 | |
| IKDFLDEHYDIPKIS | 516 | Q8NEM2 | |
| PYEKDEKPINKSEHL | 146 | Q9UHV7 | |
| IDKISEHVEEAKKLY | 46 | Q13277 | |
| DYVEHAKEETKKAIK | 241 | P32856 | |
| HINKLDKYDSVEAIK | 1021 | Q13591 | |
| YVLTDHKKDLLEVPE | 221 | O60284 | |
| EEHETDEKRGKIYKP | 146 | O15042 | |
| RYQIKPLKSTDEKEH | 156 | O15204 | |
| LHSPVKRKLEAEKDY | 216 | Q8N8U2 | |
| PIKKTVHFEADTYKD | 421 | Q96JQ2 | |
| HSKLKKENPDIYEEN | 296 | Q7Z624 | |
| TERAKKAHLKPYEEI | 141 | Q8WW14 | |
| ELKFDEKNKKAPEHY | 646 | Q9NRU3 | |
| KDLEKQYNKEEPHLS | 301 | Q96N96 | |
| KQLHAKIDAAEEEKY | 66 | P48788 | |
| KKFKLEPHDDQVFLD | 166 | Q99442 | |
| KEHFEKAIELNPKDA | 191 | Q96DB5 | |
| AKDYPAHTEEDKQIQ | 286 | Q96DB5 | |
| HRVEVKKAVPKEDIY | 166 | Q13151 | |
| QKEALAEKEHKLEEY | 251 | Q96P16 | |
| FKLKEDYEKIQHLEQ | 241 | Q15431 | |
| CEKQDYEAHPKIKEI | 681 | Q9UBT6 | |
| KFLEVDEYPEHIKNL | 571 | Q96K76 | |
| EEKKRHSYFEKPKVD | 376 | Q13123 | |
| KSPEDHLLYVSELEK | 1066 | Q63HK5 | |
| NKIHTGEKLYKPEDV | 781 | P17038 | |
| YILDSSPEKLHKELE | 191 | Q8N5H7 | |
| DIHIKPEHYSELIKK | 166 | Q8TBZ6 | |
| SEELDPQKYHDLAKL | 276 | Q9UL62 | |
| KHVQEFYKLDEDIIP | 1011 | Q5SVZ6 | |
| KAPLYDLAAHEDKVL | 376 | Q9GZL7 | |
| LEQRKEPYKVKIHET | 56 | B4DXR9 | |
| VQEKVHSVEKPYKCE | 641 | Q9NZL3 | |
| DYKSILEKDPSIHQA | 211 | Q99614 | |
| KAKHEEVKELYQRLP | 466 | Q86UV5 | |
| LQKDEYKPEKALSEE | 826 | Q9NYI0 | |
| KPEKDARHVVKVEYQ | 51 | Q86Y07 | |
| HEVDKLYKVENKPAL | 61 | Q9H267 | |
| LRKHVVQKKPYECEE | 351 | Q8NC26 | |
| ALYSAEKPKLEDEHL | 61 | Q8NFU3 | |
| FDNEEKDKEYKPHSI | 181 | P41229 | |
| HPKDQEVFLKTKDDA | 716 | Q9NR99 | |
| YPTKHEEINNIKKKD | 1396 | Q8NEV4 | |
| KDLEYHLDPKTKELP | 46 | Q9Y4I1 | |
| VGDHSKLYLKNPDKE | 961 | P54296 | |
| TEKEADKKPEAFVNH | 376 | O60237 |